#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14426	16S	1529	1529	100.0	16S.l15.c4.ctg.1	1943	734.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1391	1391	C	814	C	746	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14426	16S	1529	1529	100.0	16S.l15.c4.ctg.1	1943	734.5	0	HET	.	.	.	T1412TGGGGG,TGGGGGG	.	1412	1412	T	1619	1619	T	830	TGGGGG,TGGGGGG	364,354	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14426	16S	1529	1529	100.0	16S.l15.c4.ctg.1	1943	734.5	0	HET	.	.	.	C1525T	.	1525	1525	C	1732	1732	C	692	C,T	335,304	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26544	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3479	760.3	0	.	n	.	0	T695C	SNP	695	695	T	1030	1030	C	845	C	793	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26544	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3479	760.3	0	.	n	.	0	A1638G	SNP	1638	1638	A	1973	1973	G	857	G	801	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26544	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3479	760.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2306	2306	C	842	C	764	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26544	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3479	760.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2380	2380	A	830	A	776	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26544	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3479	760.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2932	2932	C	834	C	776	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2050	folP	855	855	100.0	folP.l15.c4.ctg.1	1544	132.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1026	1028	AGC	241;240;238	A;G;C	225;221;218	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5260	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3272	160.2	1	SNP	p	S91F	1	.	.	271	273	TTC	560	562	TTC	189;188;189	T;T;C	170;171;169	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5260	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3272	160.2	1	SNP	p	G95N	0	.	.	283	285	GGC	572	574	GGC	190;190;189	G;G;C,T	174;172;169,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5260	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3272	160.2	1	SNP	p	D95G	1	.	.	283	285	GGC	572	574	GGC	190;190;189	G;G;C,T	174;172;169,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	27	1654	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1249	131.6	1	SNP	p	G45D	0	.	.	133	135	GGC	429	431	GGC	215;215;213	G;G;C	200;200;197	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	814	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	866	93.4	0	.	n	.	0	.206T	INS	206	206	T	547	547	T	217	T	201	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5164	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2843	180.8	1	SNP	p	D86N	0	.	.	256	258	GAC	530	532	GAC	222;221;222	G;A;C	202;198;205	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5164	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2843	180.8	1	SNP	p	R87I	0	.	.	259	261	CGT	533	535	CGT	219;220;219	C,A;G,T;T	204,1;204,1;201	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5164	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2843	180.8	1	SNP	p	R87W	0	.	.	259	261	CGT	533	535	CGT	219;220;219	C,A;G,T;T	204,1;204,1;201	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5164	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2843	180.8	1	SNP	p	S87R	1	.	.	259	261	CGT	533	535	CGT	219;220;219	C,A;G,T;T	204,1;204,1;201	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5164	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2843	180.8	1	SNP	p	S88P	0	.	.	262	264	TCC	536	538	TCC	221;223;227	T;C;C	205;207;210	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4190	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2733	152.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1550	1552	GGC	217;214;213	G;G;C	194;187;189	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3956	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2463	160.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1322	1324	GCA	212;215;216	G,A;C;A	190,1;193;196	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3956	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2463	160.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1325	1327	ATC	214;215;217	A;T;C	195;196;197	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3956	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2463	160.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1337	1339	GTG	229;229;229	G;T;G,T,A	208;211;206,1,1	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3956	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2463	160.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1337	1339	GTG	229;229;229	G;T;G,T,A	208;211;206,1,1	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3956	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2463	160.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1841	1843	ACC	223;221;220	A;C;C	195;193;196	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3956	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2463	160.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1895	1897	GCG	202;198;200	G;C,G;G	172;161,1;165	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3956	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2463	160.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1895	1897	GCG	202;198;200	G;C,G;G	172;161,1;165	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3956	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2463	160.0	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2018	2020	AGC	160;160;161	A;G;C	146;144;147	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3956	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2463	160.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2027	2029	GGC	160;157;156	G;G;C	143;142;139	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3956	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2463	160.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2045	2047	CCG	137;139;138	C,CA;C,G;G	106,1;107,2;107	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5652	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	2999	188.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1615	1617	CCG	185;186;186	C;C;G	162;171;170	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2260	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1775	126.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	522	522	C	188	C	172	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	202	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	394	7.8	0	.	p	.	0	S271T	NONSYN	811	813	TCG	143	145	ACT	13;12;10	A;C;T	11;10;8	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	202	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	394	7.8	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	149	151	GAT	6;4;3	G;A;T	5;4;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	202	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	394	7.8	0	.	p	.	0	D274S	NONSYN	820	822	GAT	152	154	AGT	3;3;3	A;G;T	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	202	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	394	7.8	0	.	p	.	0	N277H	NONSYN	829	831	AAC	161	163	CAC	4;4;4	C;A;C	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	202	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	394	7.8	0	.	p	.	0	R307E	NONSYN	919	921	AGA	251	253	GAA	5;5;5	G;A;A	5;5;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	202	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	394	7.8	0	.	p	.	0	T311A	NONSYN	931	933	ACA	263	265	GCA	4;4;4	G;C;A	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	202	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	394	7.8	0	.	p	.	0	E312D	NONSYN	934	936	GAA	266	268	GAC	4;4;4	G;A;C	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	202	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	394	7.8	0	.	p	.	0	F314I	NONSYN	940	942	TTC	272	274	ATC	4;4;4	A;T;C	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	202	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	394	7.8	0	.	p	.	0	A316S	NONSYN	946	948	GCG	278	280	TCG	4;4;4	T;C;G	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	202	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	394	7.8	0	.	p	.	0	V318A	NONSYN	952	954	GTC	284	286	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	202	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	394	7.8	0	.	p	.	0	G319S	NONSYN	955	957	GGC	287	289	AGC	2;2;2	A;G;C	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	202	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	394	7.8	0	.	p	.	0	G320A	NONSYN	958	960	GGT	290	292	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	202	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	394	7.8	0	.	p	.	0	G322V	NONSYN	964	966	GGT	296	298	GTT	3;3;3	G;T;T	3;3;3	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2794	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1445	191.7	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	680	682	CAA	204;208;209	C;A;A	192;193;195	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2794	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1445	191.7	0	.	p	.	0	E212S	NONSYN	634	636	GAA	887	889	AGT	210;211;215	A;G;T	196;197;196	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2794	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1445	191.7	0	.	p	.	0	H213D	NONSYN	637	639	CAT	890	892	GAT	211;211;215	G;A,G;T	196;198,1;202	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2794	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1445	191.7	0	.	p	.	0	V215A	NONSYN	643	645	GTT	896	898	GCT	206;208;214	G;C;T	197;199;206	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2794	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1445	191.7	0	.	p	.	0	I218M	NONSYN	652	654	ATC	905	907	ATG	216;216;213	A;T;G,C	205;204;199,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2794	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1445	191.7	0	.	p	.	0	R257K	NONSYN	769	771	AGG	1022	1024	AAG	240;240;240	A;A;G	221;222;222	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2794	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1445	191.7	1	SNP	p	G120K	0	.	.	358	360	GGC	611	613	GGC	208;207;206	G;G;C	195;194;193	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10190	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4742	214.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1108	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	911	120.2	1	SNP	p	V57M	1	.	.	169	171	ATG	473	475	ATG	222;222;220	A;T;G	207;204;203	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
